Catheter Precision Inc. Announces Share Issue, Potential Dilution for Investors

Reuters

05-31

<a href="https://laohu8.com/S/VTAK">Catheter Precision Inc.</a> Announces Share Issue, Potential Dilution for Investors

Catheter Precision Inc. has announced a share issue that could lead to significant dilution for current investors. The company plans to issue 1,748,666 new shares of common stock, which will adjust the net tangible book value. As of March 31, 2025, the net tangible book value was reported at $(15.8) million, or $(1.71) per share. The share issuance is expected to bring this value to $(15.84) million, or $(1.44) per share. Additionally, the company has reserved 880,365 shares for future issuance under equity incentive plans. The issuance of these shares, along with the potential exercise of stock options and warrants, may further dilute the ownership of current shareholders. Catheter Precision Inc. plans to offer 4,333,333 shares at the market, with the last reported sale price being $0.30 per share, aiming to raise approximately $1.3 million in gross proceeds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-018985), on May 30, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2539270247"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539270247\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2539270247?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-31 04:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539270247","market":"nz","top_or_hot":-1,"title":"Catheter Precision Inc. Announces Share Issue, Potential Dilution for Investors","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/VTAK\">Catheter Precision Inc.</a> Announces Share Issue, Potential Dilution for Investors\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Catheter Precision Inc. has announced a share issue that could lead to significant dilution for current investors. The company plans to issue 1,748,666 new shares of common stock, which will adjust the net tangible book value. As of March 31, 2025, the net tangible book value was reported at $(15.8) million, or $(1.71) per share. The share issuance is expected to bring this value to $(15.84) million, or $(1.44) per share. Additionally, the company has reserved 880,365 shares for future issuance under equity incentive plans. The issuance of these shares, along with the potential exercise of stock options and warrants, may further dilute the ownership of current shareholders. Catheter Precision Inc. plans to offer 4,333,333 shares at the market, with the last reported sale price being $0.30 per share, aiming to raise approximately $1.3 million in gross proceeds.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-018985), on May 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Catheter Precision Inc. Announces Share Issue, Potential Dilution for Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCatheter Precision Inc. Announces Share Issue, Potential Dilution for Investors\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-31 04:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/VTAK\">Catheter Precision Inc.</a> Announces Share Issue, Potential Dilution for Investors\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Catheter Precision Inc. has announced a share issue that could lead to significant dilution for current investors. The company plans to issue 1,748,666 new shares of common stock, which will adjust the net tangible book value. As of March 31, 2025, the net tangible book value was reported at $(15.8) million, or $(1.71) per share. The share issuance is expected to bring this value to $(15.84) million, or $(1.44) per share. Additionally, the company has reserved 880,365 shares for future issuance under equity incentive plans. The issuance of these shares, along with the potential exercise of stock options and warrants, may further dilute the ownership of current shareholders. Catheter Precision Inc. plans to offer 4,333,333 shares at the market, with the last reported sale price being $0.30 per share, aiming to raise approximately $1.3 million in gross proceeds.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-018985), on May 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL18KRgh:1","article_id":"2539270247","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539270247","pubTimestamp":1748636197,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Catheter Precision Inc. has announced a share issue that could lead to significant dilution for current investors. The company plans to issue 1,748,666 new shares of common stock, which will adjust the net tangible book value. As of March 31, 2025, the net tangible book value was reported at $ million, or $ per share. The share issuance is expected to bring this value to $ million, or $ per share. Additionally, the company has reserved 880,365 shares for future issuance under equity incentive plans. The issuance of these shares, along with the potential exercise of stock options and warrants, may further dilute the ownership of current shareholders. Catheter Precision Inc. plans to offer 4,333,333 shares at the market, with the last reported sale price being $0.30 per share, aiming to raise approximately $1.3 million in gross proceeds.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Catheter Precision Inc.宣布发行股票，可能会稀释投资者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTAK":0.9},"content_text":"Catheter Precision Inc. Announces Share Issue, Potential Dilution for Investors\n    \n\n        Catheter Precision Inc. has announced a share issue that could lead to significant dilution for current investors. The company plans to issue 1,748,666 new shares of common stock, which will adjust the net tangible book value. As of March 31, 2025, the net tangible book value was reported at $(15.8) million, or $(1.71) per share. The share issuance is expected to bring this value to $(15.84) million, or $(1.44) per share. Additionally, the company has reserved 880,365 shares for future issuance under equity incentive plans. The issuance of these shares, along with the potential exercise of stock options and warrants, may further dilute the ownership of current shareholders. Catheter Precision Inc. plans to offer 4,333,333 shares at the market, with the last reported sale price being $0.30 per share, aiming to raise approximately $1.3 million in gross proceeds.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-018985), on May 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}